In this study, we demonstrate that FGFR1 overexpression significantly attenuated the palbociclib-induced inhibition of CSC stemness of breast cancer cells, as indicated by the anchorage-independent growth and tumorsphere assays that detect CSC self-renewal. This evidence concerns the gene FGFR1 and breast cancer.